HSBC
Brokerage firm HSBC has a “buy” rating on the stock with a price target of ₹1,420 per share, indicating an upside of 19% from its previous closing price of ₹1,192.9 apiece.
HSBC said the company’s India revenue grew by high-single digits, which is mid-single digit volume growth and its consolidated revenue increased by double digits.
The company’s home care vertical growth was broad-based, with double digit value and volume growth. The performance of its India business, excluding soaps, remained very strong, HSBC said.The brokerage estimates the company’s margin to pick up in the second half of the ongoing financial year. It did not see any change in guidance.
CLSA
Brokerage firm CLSA has an “underperform” rating on GCPL with a target of ₹1,062 per share, implying a potential downside of nearly 11% from its previous closing price.CLSA said the company indicated high, single-digit sales growth for standalone business, with mid-single digit underlying volume growth — slightly below forecast of 10% standalone growth.
The company’s consolidated rupee revenue growth is likely to be double digits, which is broadly in line with estimates of 11%, CLSA said.
The brokerage said it remains cautious as it believes investor expectation of mid-teen value growth for FY26 might be too high.
Of the 38 analysts that have coverage on the stock, 29 have a “buy” rating, seven have a “hold” rating and two have a “sell” rating.
GCPL shares gained 6% to hit an intraday high of ₹1,264 apiece on Monday, July 7. The stock was up 4.8% at ₹1,246.7 apiece at 10.15 am.
Also Read: Kalyan Jewellers Q1 Update: Akshaya Tritiya, wedding season contribute to 31% growth
